Meihua International Medical Technologies
MHUA
MHUA was delisted on the 8th of December, 2025.
0 hedge funds and large institutions have $0 invested in Meihua International Medical Technologies in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
0.06% less ownership
Funds ownership: 0.06% → 0% (-0.06%)
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $135K → $0 (-$135K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$134K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
MHUA Hedge Fund Activity: Q2 2022 in Review
0 of the 5,960 institutional investors tracked by Wall St. Rank reported a position in Meihua International Medical Technologies (MHUA) for Q2 2022, worth a combined $0 — down 100% from $135K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of MHUA and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Millennium Management, exiting entirely with an estimated $134K sold.
- 0 institutional investors held Meihua International Medical Technologies (MHUA) as of Q2 2022, down from 2 in Q1 2022.
- Funds reported $0 of Meihua International Medical Technologies stock for Q2 2022, down 100% quarter-over-quarter.
- 0 funds opened new Meihua International Medical Technologies positions in Q2 2022 and 2 closed out, a net change of -2 holders.
- The largest Meihua International Medical Technologies seller in Q2 2022 was Millennium Management, an estimated $134K sold.
Based on aggregated 13F filings for Q2 2022.